one hundred and thirty-five patients with bacterial pneumonia who had risk factors ( alcoholism , chronic obstructive pulmonary disease , corticosteroid therapy diabetes mellitus , advanced age , solid tumours ) were randomly allocated in a double-blind fashion to receive either ceftizoxime ( 2-4 g every 8 h ) , cefotaxime ( 1-2 g every 4 h ) , or latamoxef ( 2-4 g every 8 h ) .
C0007560
ceftizoxime
C0007554
cefotaxime